Document is current
Any future updates will be listed below
-
Authors
Li, Siran
Alexander, Joan
Kendall, Jude
Andrews, Peter
Rose, Elizabeth
Orjuela, Hope
Park, Sarah
Podszus, Craig
Shanley, Liam
Ranade, Nissim
Morris, Patrick
Stauder, Danielle
Bradford, Daniel
Laster, Zachary
Ronemus, Michael
Rishi, Arvind
Frimer, Marina
Ma, Rong
Donoho, David L.
Goldberg, Gary L.
Wigler, Michael
Levy, Dan
-
Funding
Funding for this research was provided by:
Simons Foundation (519054)
Breast Cancer Research Foundation
- License Information
-
More Information
Article History
Received: 14 September 2024
Accepted: 14 September 2025
First Online: 27 September 2025
Declarations
:
: Women presenting to the Department of Obstetrics and Gynecology at the Long Island Jewish Medical Center (LIJMC) at Northwell Health with a clinical suspicion of ovarian or endometrial cancer (type I or type II) were prospectively enrolled between October 2018 and March 2021 as part of an ongoing study of endometrial and ovarian cancers. The hybrid BAG-seq method was applied to blood and tissue biopsies collected from five patients (P1–P5) who underwent total hysterectomy and bilateral salpingo-oophorectomy at LIJMC. All patients provided individual informed consent. The study (TAP#1805) was approved by the Northwell Health Biospecimen Repository Committee on Tissue Governance and Protocol Support. Demographic and clinical data related to uterine cancer diagnoses were collected and maintained in the Department of Obstetrics and Gynecology database at Northwell Health. All procedures were performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.
